Help guide our efforts to modernize
Send us your comments by March 14, 2020. Menu

Monoclonal Antibody-Based Sequential Therapy for Deep Remission in Multiple Myeloma (MASTER)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details. Identifier: NCT03224507
Recruitment Status : Recruiting
First Posted : July 21, 2017
Last Update Posted : March 26, 2019
Janssen Scientific Affairs, LLC
Information provided by (Responsible Party):
Luciano Jose Costa, MD, University of Alabama at Birmingham

No Study Results Posted on for this Study
Recruitment Status : Recruiting
Estimated Primary Completion Date : April 1, 2021
Estimated Study Completion Date : April 1, 2023